Cargando…
How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-world Cohort
INTRODUCTION: The aim of this work is to propose Boolean-defined low disease activity (LDA) and to test its utility in rheumatoid arthritis (RA). METHODS: We used data from a longitudinal academic clinical database of RA in Peking University First Hospital over a decade. The initial proposal of Bool...
Autores principales: | Xie, Wenhui, Li, Guangtao, Huang, Hong, Zhang, Zhuoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991037/ https://www.ncbi.nlm.nih.gov/pubmed/33355913 http://dx.doi.org/10.1007/s40744-020-00270-z |
Ejemplares similares
-
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience
por: Xie, Wenhui, et al.
Publicado: (2023) -
Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts
por: Huang, Hong, et al.
Publicado: (2022) -
Overlapping Sjogren’s syndrome reduces the probability of reaching target in rheumatoid arthritis patients: a propensity score matched real-world cohort from 2009 to 2019
por: Zhang, Huijuan, et al.
Publicado: (2020) -
Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019) -
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
por: An, Yuan, et al.
Publicado: (2016)